Mixed oxo-hydroxy bile acids as actual or potential impurities in ursodeoxycholic acid preparation: A 1H and 13C NMR study

Farmaco

Volumn 55, Issue 1, 2000, Pages 51-55

  Bettarello, Lisa ^a   Bortolini, Olga ^a   Fantin, Giancarlo ^a   Guerrini, Alessandra ^a  

^a UNIVERSITY OF FERRARA   (Italy)

Author keywords

13C NMR; 1H NMR; Bile acids; Nuclear magnetic resonance

Indexed keywords

CHENODEOXYCHOLIC ACID; CHOLIC ACID; DEOXYCHOLIC ACID; URSODEOXYCHOLIC ACID;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CHOLESTEROL STONE; DRUG PURITY; GASTRITIS; OBSTRUCTIVE JAUNDICE; PROTON NUCLEAR MAGNETIC RESONANCE;

BILE ACIDS AND SALTS; CARBON ISOTOPES; MAGNETIC RESONANCE SPECTROSCOPY; PROTONS; URSODEOXYCHOLIC ACID;

EID: 0034018490     PISSN: 0014827X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-827X(99)00121-4     Document Type: Article

References (27)

1. Thistle J.L., Hofmann A.F. Efficacy and specificity of chenodeoxycholic acid therapy for dissolving gallstones. New Engl. J. Med. 289:1973;655-661.
2. Ward A., Brogden R.N., Heel R.C., Speight T.M., Avery G.S. Ursodeoxycholic acid. A review of its pharmacological properties and therapeutic efficacy. Drugs. 27:1984;95-131.
3. Scalia S., Pazzi P., Stabellini G., Guarneri M. HPLC assay of conjugated bile acids in gastric juice during UDCA therapy of bile reflux gastritis. J. Pharm. Biomed. Anal. 6:1988;911-917.
4. Poupon R., Poupon R.E., Calmus Y., Chretien Y., Ballet F., Darnis F. Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis? Lancet. 1:1987;834-836.
5. Beuers U., Spengler U., Kruis W., Aydemir U., Weibecke B., Heldwein W., Weinzierl M., Pope G.R., Sawerbruch T., Paumgartner G. Ursodeoxycholic acid lowers the pool size of other dihydroxy bile acids in healthy subjects, but not in patients with cholestatic liver disease. Hepatology. 16:1992;707-714.
6. Colombo C., Setchell K.D.R., Podda M., Curcio L., Ronchi M., Giunta A. The effects of ursodeoxycholic acid therapy in liver disease associated with cystic fibrosis. J. Pediatr. 117:1990;482-489.
7. Bortolini O., Medici A., Poli S. Biotransformations on steroid nucleus of bile acids. Steroids. 62:1997;564-577.
8. Bortolini O., Fantin G., Medici A., Pedrini P. Key fragmentations for the interpretation of mass spectra of disubstituted bile acids of bovine and porcine origin. Rapid Commun. Mass Spectrom. 11:1997;1286-1288. and references therein.
9. DiDonato G.C., Warrack B.M. Ion spray liquid chromatographic/mass spectrometric characterization of bile acids. Biol. Mass Spectrom. 22:1993;101-111.
10. Roda A., Cerrè C., Simoni P., Polimeni C., Vaccari C., Pistillo A. Determination of free and amidated bile acids by high-performance liquid chromatography with evaporative light-scattering mass detection. J. Lipid Res. 33:1992;1393-1402.
11. Brane S., Kirk D.N. The Bile Acids, Chemistry, Pyisiology and Metabolism. 4:1988;Plenum, New York. and references therein.
12. Zurcher R.F. Progress in Nuclear Magnetic Resonance Spectroscopy In Organic Chemistry. 1969;Pergamon, Oxford.
13. 1H NMR spectra of oxo bile acids. Ann. Chim. (Rome). 89:1999;319-322.
14. Jackman L.M., Sternhell S. Applications of Nuclear Magnetic Resonance Spectoscopy in Organic Chemistry. 1969;Pergamon, Oxford.
15. Bhacca N.S., Wehrli F.W., Fischer N.H. Carbon-13 magnetic resonance study of terpenoids. An application of heteronuclear selective decoupling experiments to the spectral assignments of nonproton-bearing carbon-13 resonances of a germacranolide, melampodin. J. Org. Chem. 38:1973;3618-3622.
16. 2O, Cryst. Struct. Comm. 11 (1982) 1787-1792. AM1 calculations have shown that the structure is slightly distorted in the presence of oxo groups. Functions at C-3, C-7, C-12 and side chain have been omitted for clarity.
17. Note that the nomenclature axial-equatorial refers to ring B and the configurational assignment of the proton at C-6 as axial is proposed by analogy with other protons under discussion. The experimental results and the dihedral angle of ca. 90°, however, are consistent with both axial and equatorial configuration for the proton at C-6.
18. 3 of compound 1 are already reported, see Ref. [22].
19. 13C NMR spectra of steroids. A survey and commentary. Org. Magn. Reson. 9:1977;439-464. and references therein.
20. Smith W.B. Webb G.A. Annual Reports in NMR Spectroscopy. 8:1978;199 Academic Press, New York. and references therein.
21. Leibfritz D., Roberts J.B. Nuclear magnetic resonance spectroscopy. Carbon-13 spectra of cholic acids and hydrocarbons included in sodium deoxycholate solutions. J. Am. Chem. Soc. 95:1973;4996-5003.
22. Iida T., Tamura T., Matsumoto T., Chang F. Carbon-13 NMR spectra of hydroxylated bile acid stereoisomers. Org. Magn. Reson. 21:1983;305-309.
23. Iida T., Tamura T., Matsumoto T., Chang F. Carbon-13 NMR spectra of oxobile acid methyl esters. J. Jpn. Oil Chem. Soc. 32:1983;232-233.
24. Breitmaier E., Voelter W. Carbon-13 NMR Spectroscopy. third ed. 1987;120-121 VCH, Weinhem.
25. Fantin G., Fogagnolo M., Medici A., Pedrini P., Cova U. Synthesis of 7- and 12-hydroxy and 7,12-dihydroxy-3-keto-5β-cholan-24-oic acids by reduction of 3,7-, 3,12 and 3,7,12-oxo derivatives. Steroids. 58:1993;524-526.
26. Fantin G., Ferrarini S., Medici A., Pedrini P., Poli S. Regioselective microbial oxidation of bile acids. Tetrahedron. 54:1998;1937-1942.
27. Riva S., Bovara R., Pasta P., Carrea G. Preparative-scale regio- and stereospecific oxidoreduction of cholic acid and dehydrocholic acid catalyzed by hydroxysteroid dehydrogenase. J. Org. Chem. 51:1986;2902-2906.